975 related articles for article (PubMed ID: 16143565)
21. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
22. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
Berini CA; Pando MA; Bautista CT; Eirin ME; Martinez-Peralta L; Weissenbacher M; Avila MM; Biglione MM
J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
[TBL] [Abstract][Full Text] [Related]
23. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
25. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit".
de la Fuente L; Toro C; Brugal MT; Vallejo F; Soriano V; Barrio G; Ballesta R; Bravo MJ;
J Clin Virol; 2007 Jan; 38(1):87-90. PubMed ID: 17088099
[TBL] [Abstract][Full Text] [Related]
26. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Lutsar I; Huik K
Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
28. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
29. [Cohort study methodology of the ITINERE Project on heroin users in three Spanish cities and main characteristics of the participants].
de la Fuente de Hoz L; Brugal Puig MT; Ballesta Gómez R; Bravo Poetela MJ; Barrio Anta G; Domingo Salvany A; Silva do Rosario T; Ambrós Hortensi M;
Rev Esp Salud Publica; 2005; 79(4):475-91. PubMed ID: 16465964
[TBL] [Abstract][Full Text] [Related]
30. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
[TBL] [Abstract][Full Text] [Related]
31. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
32. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
33. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain.
Toro C; Rodés B; Bassani S; Jiménez V; Tuset C; Brugal MT; de la Fuente L; Soriano V;
J Clin Virol; 2005 May; 33(1):65-70. PubMed ID: 15797367
[TBL] [Abstract][Full Text] [Related]
35. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
36. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
37. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
[TBL] [Abstract][Full Text] [Related]
38. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
[TBL] [Abstract][Full Text] [Related]
40. [Rate of infection by blood-borne viruses in active heroin users in 3 Spanish cities].
Bassani S; Toro C; de la Fuente L; Brugal MT; Jiménez V; Soriano V
Med Clin (Barc); 2004 Apr; 122(15):570-2. PubMed ID: 15144744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
